🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
66.89
-1.71 (-2.49%)
At close: Nov 20, 2026, 4:00 PM EST
67.48
+0.59 (0.89%)
After-hours: Nov 20, 2026, 7:30 PM EST

Globus Medical Statistics

Total Valuation

Globus Medical has a market cap or net worth of $8.86 billion. The enterprise value is $8.10 billion.

Market Cap8.86B
Enterprise Value 8.10B

Important Dates

The last earnings date was Thursday, November 5, 2026, after market close.

Earnings Date Nov 5, 2026
Ex-Dividend Date n/a

Share Statistics

Globus Medical has 132.47 million shares outstanding. The number of shares has decreased by -0.58% in one year.

Current Share Class 110.04M
Shares Outstanding 132.47M
Shares Change (YoY) -0.58%
Shares Change (QoQ) -1.00%
Owned by Insiders (%) 17.41%
Owned by Institutions (%) 91.91%
Float 109.14M

Valuation Ratios

The trailing PE ratio is 16.47 and the forward PE ratio is 12.95. Globus Medical's PEG ratio is 1.00.

PE Ratio 16.47
Forward PE 12.95
PS Ratio 2.82
Forward PS 2.77
PB Ratio 1.85
P/TBV Ratio 3.31
P/FCF Ratio 11.56
P/OCF Ratio 9.57
PEG Ratio 1.00
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.90, with an EV/FCF ratio of 10.56.

EV / Earnings 14.52
EV / Sales 2.58
EV / EBITDA 7.90
EV / EBIT 10.85
EV / FCF 10.56

Financial Position

The company has a current ratio of 4.30, with a Debt / Equity ratio of 0.02.

Current Ratio 4.30
Quick Ratio 2.44
Debt / Equity 0.02
Debt / EBITDA 0.10
Debt / FCF 0.14
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is 12.13% and return on invested capital (ROIC) is 13.97%.

Return on Equity (ROE) 12.13%
Return on Assets (ROA) 10.50%
Return on Invested Capital (ROIC) 13.97%
Return on Capital Employed (ROCE) 14.86%
Weighted Average Cost of Capital (WACC) 9.37%
Revenue Per Employee $523,268
Profits Per Employee $92,939
Employee Count6,000
Asset Turnover 0.59
Inventory Turnover 1.21

Taxes

In the past 12 months, Globus Medical has paid $141.76 million in taxes.

Income Tax 141.76M
Effective Tax Rate 20.27%

Stock Price Statistics

The stock price has decreased by -20.20% in the last 52 weeks. The beta is 0.95, so Globus Medical's price volatility has been similar to the market average.

Beta (5Y) 0.95
52-Week Price Change -20.20%
50-Day Moving Average 75.97
200-Day Moving Average 82.22
Relative Strength Index (RSI) 35.16
Average Volume (20 Days) 2,050,814

Short Selling Information

The latest short interest is 9.46 million, so 7.14% of the outstanding shares have been sold short.

Short Interest 9.46M
Short Previous Month 8.44M
Short % of Shares Out 7.14%
Short % of Float 8.66%
Short Ratio (days to cover) 7.12

Income Statement

In the last 12 months, Globus Medical had revenue of $3.14 billion and earned $557.64 million in profits. Earnings per share was $4.06.

Revenue3.14B
Gross Profit 2.18B
Operating Income 746.08M
Pretax Income 699.39M
Net Income 557.64M
EBITDA 1.03B
EBIT 746.08M
Earnings Per Share (EPS) $4.06
Full Income Statement

Balance Sheet

The company has $871.17 million in cash and investments and $108.19 million in debt, with a net cash position of $762.99 million or $5.76 per share.

Cash & Investments 871.17M
Total Debt 108.19M
Net Cash 762.99M
Net Cash Per Share $5.76
Equity (Book Value) 4.80B
Book Value Per Share 36.15
Working Capital 1.67B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $925.92 million and capital expenditures -$159.37 million, giving a free cash flow of $766.55 million.

Operating Cash Flow 925.92M
Capital Expenditures -159.37M
Depreciation & Amortization 279.22M
Net Borrowing n/a
Free Cash Flow 766.55M
FCF Per Share $5.79
Full Cash Flow Statement

Margins

Gross margin is 69.33%, with operating and profit margins of 23.76% and 17.76%.

Gross Margin 69.33%
Operating Margin 23.76%
Pretax Margin 22.28%
Profit Margin 17.76%
EBITDA Margin 32.66%
EBIT Margin 23.76%
FCF Margin 24.42%

Dividends & Yields

Globus Medical does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield 0.58%
Shareholder Yield 0.58%
Earnings Yield 6.07%
FCF Yield 8.65%
Dividend Details

Analyst Forecast

The average price target for Globus Medical is $93.43, which is 39.68% higher than the current price. The consensus rating is "Buy".

Price Target $93.43
Price Target Difference 39.68%
Analyst Consensus Buy
Analyst Count 15
Revenue Growth Forecast (3Y) 5.58%
EPS Growth Forecast (3Y) 13.89%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside
Graham Formula Value
Graham Formula Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Globus Medical has an Altman Z-Score of 10.86 and a Piotroski F-Score of 7.

Altman Z-Score 10.86
Piotroski F-Score 7